{"issuance_frequency":"","notes_translated":{"fr":"Les présentes lignes directrices constituent une adaptation aux fins d’utilisation au Canada du guide technique publié par l’Organisation mondiale de la Santé (OMS) intitulé \"Prise en charge clinique de l’infection respiratoire aiguë sévère lorsqu’une infection par le nouveau coronavirus (2019-nCoV) est soupçonnée, 13 mars 2020\". Les données scientifiques et les opinions d’experts dont on dispose présentement ont éclairé la rédaction des présentes lignes directrices, qui sont susceptibles de changer en fonction de l’évolution des connaissances.","en":"This guidance has been adapted for Canadian use from the WHO document entitled \"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected – Interim guidance - 13 March 2020\". This guidance is informed by currently available scientific evidence and expert opinion, and is subject to change as new information becomes available."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"cf69ab87-c86e-4a6e-be12-e193cfe98383","metadata_created":"2020-05-01T20:11:28.974236","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-09-24T18:31:04.757017","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-05-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Prise en charge clinique","des patients","atteints de la COVID-19","lignes directrices","provisoires pour","la prise","en charge clinique"],"en":["Clinical management","of patients","with COVID-19","Clinical management","interim guidance."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Prise en charge clinique des patients atteints d’une forme modérée ou grave de la COVID 19 – Lignes directrices provisoires","en":"Clinical management of patients with moderate to severe COVID-19 - Interim guidance"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"cf69ab87-c86e-4a6e-be12-e193cfe98383","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"58e77bb0-bf88-43aa-97a3-8b930b559465","related_relationship":"","name_translated":{"fr":"Prise en charge clinique des patients atteints d’une forme modérée ou grave de la COVID 19 – Lignes directrices provisoires","en":"Clinical management of patients with moderate to severe COVID-19 - Interim guidance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Clinical management of patients with moderate to severe COVID-19 - Interim guidance","language":["en"],"created":"2020-05-01T20:11:29.116874","url":"https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/clinical-management-covid-19.html","last_modified":null,"position":0,"revision_id":"d3888c04-611f-4e4d-b22e-3824a58f229d","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"cf69ab87-c86e-4a6e-be12-e193cfe98383","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5ddfcf59-c4e7-4bdd-869c-f179eef7ae05","related_relationship":"","name_translated":{"fr":"Prise en charge clinique des patients atteints d’une forme modérée ou grave de la COVID 19 – Lignes directrices provisoires","en":"Clinical management of patients with moderate to severe COVID-19 - Interim guidance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Clinical management of patients with moderate to severe COVID-19 - Interim guidance","language":["fr"],"created":"2020-05-01T20:11:29.116880","url":"https://www.canada.ca/fr/sante-publique/services/maladies/2019-nouveau-coronavirus/professionnels-sante/prise-charge-clinique-covid19.html","last_modified":null,"position":1,"revision_id":"d3888c04-611f-4e4d-b22e-3824a58f229d","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-04-02 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"cf69ab87-c86e-4a6e-be12-e193cfe98383","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guidance has been adapted for Canadian use from the WHO document entitled \"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected – Interim guidance - 13 March 2020\". This guidance is informed by currently available scientific evidence and expert opinion, and is subject to change as new information becomes available.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Clinical management of patients with moderate to severe COVID-19 - Interim guidance","revision_id":"85eb286c-ea3c-4f0f-9c9d-61f145024ba6"}